These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 15451765

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interest in breast cancer chemoprevention among older women.
    Tjia J, Micco E, Armstrong K.
    Breast Cancer Res Treat; 2008 Apr; 108(3):435-53. PubMed ID: 17554628
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acceptance of tamoxifen chemoprevention by physicians and women at risk.
    Tchou J, Hou N, Rademaker A, Jordan VC, Morrow M.
    Cancer; 2004 May 01; 100(9):1800-6. PubMed ID: 15112259
    [Abstract] [Full Text] [Related]

  • 9. Venous thromboembolic disease and stroke in women taking tamoxifen for breast cancer chemoprevention.
    Isaacs C.
    Clin Adv Hematol Oncol; 2005 Dec 01; 3(12):913-4. PubMed ID: 16555431
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
    Decensi A, Maisonneuve P, Rotmensz N, Bettega D, Costa A, Sacchini V, Salvioni A, Travaglini R, Oliviero P, D'Aiuto G, Gulisano M, Gucciardo G, del Turco MR, Pizzichetta MA, Conforti S, Bonanni B, Boyle P, Veronesi U, Italian Tamoxifen Study Group.
    Circulation; 2005 Feb 08; 111(5):650-6. PubMed ID: 15699284
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.
    Duggan C, Marriott K, Edwards R, Cuzick J.
    J Clin Oncol; 2003 Oct 01; 21(19):3588-93. PubMed ID: 14512389
    [Abstract] [Full Text] [Related]

  • 15. The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial.
    Kinney AY, Richards C, Vernon SW, Vogel VG.
    Prev Med; 1998 Oct 01; 27(5 Pt 1):713-9. PubMed ID: 9808803
    [Abstract] [Full Text] [Related]

  • 16. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N, Costantino JP, Garber JE, Berliner N, Wickerham DL, Wolmark N.
    J Natl Cancer Inst; 2006 Jul 05; 98(13):904-10. PubMed ID: 16818854
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Validation of a model predicting enrollment status in a chemoprevention trial for breast cancer.
    Yeomans Kinney A, Vernon SW, Shui W, Weber DV, Schell M, Vogel VG.
    Cancer Epidemiol Biomarkers Prev; 1998 Jul 05; 7(7):591-5. PubMed ID: 9681527
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis.
    Ozanne EM, Esserman LJ.
    Cancer Epidemiol Biomarkers Prev; 2004 Dec 05; 13(12):2043-52. PubMed ID: 15598759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.